spironolactone for women acne
Selected indexed studies
- Guidelines of care for the management of acne vulgaris. (J Am Acad Dermatol, 2024) [PMID:38300170]
- Spironolactone for acne in women. (Drug Ther Bull, 2023) [PMID:37468231]
- Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial. (BMJ, 2023) [PMID:37192767]
_Worker-drafted node — pending editorial review._
Connections
spironolactone for women acne is a side effect of
Sources
- Guidelines of care for the management of acne vulgaris. (2024) pubmed
- Managing acne vulgaris: an update. (2023) pubmed
- Efficacy of Spironolactone Compared with Doxycycline in Moderate Acne in Adult Females: Results of the Multicentre, Controlled, Randomized, Double-blind Prospective and Parallel Female Acne Spironolactone vs doxyCycline Efficacy (FASCE) Study. (2024) pubmed
- Innovations in Acne. (2025) pubmed
- Spironolactone for acne in women. (2023) pubmed
- Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial. (2023) pubmed
- Dermatology: how to manage acne vulgaris. (2021) pubmed
- Spironolactone for the Treatment of Moderate to Severe Acne in Adult Women: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. (2025) pubmed
- Hormonal Therapies for Acne: A Comprehensive Update for Dermatologists. (2025) pubmed
- Efficacy and Safety of Oral Spironolactone for Women With Acne Vulgaris: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials With Trial Sequential Analysis. (2025) pubmed